Neuroscience Market by Type (Diagnostic Solution, Drug Therapy, Non-drug Therapy), End-User (Diagnostic Laboratories, Hospitals, Research & Academic Institutes) - Global Forecast 2024-2030

Neuroscience Market by Type (Diagnostic Solution, Drug Therapy, Non-drug Therapy), End-User (Diagnostic Laboratories, Hospitals, Research & Academic Institutes) - Global Forecast 2024-2030

The Neuroscience Market size was estimated at USD 13.77 billion in 2023 and expected to reach USD 15.11 billion in 2024, at a CAGR 10.34% to reach USD 27.42 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neuroscience Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neuroscience Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neuroscience Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Brain Products GmbH, Compumedics Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Gilson, Inc., GL Sciences Inc., Hitachi, Ltd., Illumina, Inc., JASCO Corporation, Merck KGaA, Metrohm AG, Natus Medical Incorporated, Novasep Holding SAS, PerkinElmer Inc., Pfizer Inc., Promega Corporation, QIAGEN GmbH, Restek Corporation, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., Waters Corporation, and YMC Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neuroscience Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

Diagnostic Solution
Molecular

Immunoassay

Instruments

Kits & Consumables

Liquid Chromatography

PCR

Sequencing

Software
Non-molecular

Brainstem auditory evoked potential

Electroencephalography

Imaging

Drug Therapy
Neurological disorders

Alzheimer's disease

Epilepsy

Huntington's disease

Multiple sclerosis

Parkinson's disease

Vascular dementia
Neuropsychiatric disorders

Anxiety

Attention deficit

Autism spectrum

Insomnia

Mood disorder

Substance abuse

Non-drug Therapy
Behavioral Therapy

Animal-assisted

Home-based

Inpatient

Outpatient
Digital Health Services
End-User

Diagnostic Laboratories

Hospitals

Research & Academic Institutes
Region

Americas
Argentina
Brazil
Canada
Mexico
United States

California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Neuroscience Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neuroscience Market?
3. What are the technology trends and regulatory frameworks in the Neuroscience Market?
4. What is the market share of the leading vendors in the Neuroscience Market?
5. Which modes and strategic moves are suitable for entering the Neuroscience Market?

Note: PDF & Excel + Online Access - 1 Year